Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials

مواد مشابهة

• Serious adverse effects of extended-release niacin/laropiprant: results from the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial
  حسب: Haynes, R, وآخرون
  منشور في: (2019)
• Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
  حسب: Heart Protection Study Collaborative Group
  منشور في: (2007)
• Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
  حسب: Heart Protection Study Collaborative Group
  منشور في: (2010)
• HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.
  حسب: HPS2-THRIVE Collaborative Group, وآخرون
  منشور في: (2013)
• Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study
  حسب: Pendlebury, S, وآخرون
  منشور في: (2019)